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Abstract: A common null polymorphism (rs1815739; R577X) in the gene that codes for α-actinin-
3 (ACTN3) has been related to different aspects of exercise performance. Individuals
who are homozygous for the X allele are unable to express the α-actinin-3 protein in
the muscle as opposed to those with the RX or RR genotype. α-actinin-3 deficiency in
the muscle does not result in any disease. However, the different ACTN3 genotypes
can modify the functioning of skeletal muscle during exercise through structural,
metabolic or signalling changes, as shown in both humans and in the mouse model.
Specifically, the ACTN3 RR genotype might favour the ability to generate powerful and
forceful muscle contractions. Leading to an overall advantage of the RR genotype for
enhanced performance in some speed and power-oriented sports. In addition, RR
genotype might also favour the ability to withstand exercise-induced muscle damage,
while the beneficial influence of the XX genotype on aerobic exercise performance
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needs to be validated in human studies. More information is required to unveil the
association of ACTN3 genotype with trainability and injury risk during acute or chronic
exercise.
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A common null polymorphism (rs1815739; R577X) in the gene that codes for α-
actinin-3 (ACTN3) has been related to different aspects of exercise performance. Individuals 
who are homozygous for the X allele are unable to express the α-actinin-3 protein in the 
muscle as opposed to those with the RX or RR genotype. α-actinin-3 deficiency in the muscle 
does not result in any disease. However, the different ACTN3 genotypes can modify the 
functioning of skeletal muscle during exercise through structural, metabolic or signalling 
changes, as shown in both humans and in the mouse model. Specifically, the ACTN3 RR 
genotype might favour the ability to generate powerful and forceful muscle contractions. 
Leading to an overall advantage of the RR genotype for enhanced performance in some 
speed and power-oriented sports. In addition, RR genotype might also favour the ability to 
withstand exercise-induced muscle damage, while the beneficial influence of the XX 
genotype on aerobic exercise performance needs to be validated in human studies. More 
information is required to unveil the association of ACTN3 genotype with trainability and 
injury risk during acute or chronic exercise.   
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ACE: Angiotensin converting enzyme 
CK: Creatine kinase 
KO: knockout 
mTOR: mammalian target of rapamycin 
SERCA1: Sarcoplasmic/endoplasmic reticulum calcium ATPase 1 






































































There are two muscle sarcomeric isoforms of α-actinin; α-actinin-2, and α-actinin-3, 
which are encoded by ACTN2 and ACTN3 genes, respectively (Beggs et al. 1992). The α-
actinin-2 and α-actinin-3 proteins form major components of the contractile apparatus at the 
Z-line and are structured similarly. However, α- actinin-2 is ubiquitously expressed in all 
muscle fiber types, while α-actinin-3 expression is found only in the fast type II fibers (Mills 
et al. 2001). This indicates that α-actinin-2 and 3 might have different physiological roles in 
the muscle (Lee et al. 2016). The protein α-actinin-2 plays a central role within the sarcomere 
for all types of locomotor activities and displacements (Ribeiro Ede et al. 2014) while the α-
actinin-3 role might be more related to the generation of rapid muscle force and thus, for the 
production fast and explosive movements (MacArthur et al. 2007). Further the role of α-
actinin-3 has been attributed to modulate the response to training, the recovery after exercise-
induced muscle damage and the exercise-associated risk of injury (Pickering and Kiely 
2017). 
North et al. (1999) identified a common stop-codon polymorphism (rs1815739; 
R577X) in the ACTN3 gene. Individuals who are homozygous for the X allele are unable to 
express α-actinin-3 in type II muscle fibers as opposed to those with the RX or RR genotype. 
Interestingly, individuals with the ACTN3 XX genotype compensate the deficiency of α-
actinin-3 with a higher expression of α-actinin-2 (Seto et al. 2011). This in turn might confer 
different properties to the muscle fiber altering muscle function at rest or during exercise 
(Eynon et al. 2011; Santiago et al. 2010).  Thus, the physiological effects found in XX 
homozygotes are explicitly related to lack of α-actinin-3 instead of to a reduced amount of 
α-actinins within the muscle. Although α-actinin-2 and α-actinin-3 isoforms are almost 
identical in structure, subtle differences in the interaction with other proteins might have a 
crucial effect on both the Z-line and the entire sarcomere (Lee et al. 2016; Berman and North 




































































al. 2007). Although α-actinin-3 deficiency is not translated into any muscle disease, the 
current evidence suggests that it might affect muscle physiology in athletes (Alfred et al. 
2011), healthy individuals, (Broos et al. 2015) and in some clinical populations (Pickering 
and Kiely 2018).   
Literature suggests that α-actinin-3 deficiency might play a beneficial role that would 
explain the perpetuation of the X allele through natural selection in human evolution.  It has 
been postulated that the survival of the X allele has been influenced by ambient temperature 
(Lee et al. 2016) because its frequency in human populations increases with the distance 
from central latitudes (Amorim et al. 2015; Friedlander et al. 2013).  This was confirmed by 
different researches that have found that the frequency distribution of the ACTN3 XX 
genotype averages ~25% in Asians, 18% in Caucasians, 11% in Ethiopians, and 3% in US 
African Americans and only 1% in Kenyans (Yang et al. 2007; Scott et al. 2010; Pickering 
and Kiely 2017). The relatively high frequency of the XX genotype in human populations 
living in cold environments might be related to improved acclimatization and thermogenesis, 
due to increased metabolic heat generation during muscle activities (Head et al. 2015). In 
addition, the X allele offers enhanced metabolic efficiency (MacArthur et al. 2008; 
MacArthur et al. 2007) and therefore it might have persisted as a metabolically ‘thrifty’ allele 
(MacArthur and North 2004) that could have favoured hunting in environments with scarce 
food resources (Amorim et al. 2015).  
In this review, we will discuss the recent insights into the role of α-actinin-3 in 
muscle, based on studies in humans and the Actn3 knockout (KO) mouse model. We will 
then focus on the consequences of α-actinin-3 deficiency on human exercise performance, 





































































CONSEQUENCES OF α-ACTININ-3 DEFICIENCY ON SPRINT/POWER-
ORIENTED PERFORMANCE 
The consequences of the ACTN3 genotype on human exercise performance were first 
investigated in elite athletes. Initially, it was found that the ACTN3 577XX genotype was 
under represented in sprint athletes, when compared to a control population of healthy 
untrained individuals (Yang et al. 2003). In fact, none of the Olympic power/sprint athletes 
included in this first investigation by Yang et al. (2003) were α-actinin-3 deficient (XX), 
suggesting that this genotype was unfavourable for fast and powerful muscle contractions, 
at least in elite sports.  This was replicated in several elite athlete cohorts where there is a 
higher frequency of the R allele in sprint and power disciplines (Eynon et al. 2013; Alfred 
et al. 2011; Kikuchi et al. 2014; Eynon et al. 2009; Roth et al. 2008; Ginszt et al. 2018; Niemi 
and Majamaa 2005) and demonstrated in subsequent meta-analyses ((Weyerstrass et al. 
2018; Ma et al. 2013); see Table 1 for a summary). Further, recent literature suggests that 
the presence of α-actinin-3 might be especially advantageous for sprint, and power-based 
sports but not for strength-based sports disciplines (Ben-Zaken et al. 2016; Kim et al. 2014a).  
In addition, the role of α-actinin-3 for the generation of high-intensity muscle contractions 
has been confirmed in research with non-athletes. Untrained RR individuals have a higher 
baseline strength than their XX counterparts (Walsh et al. 2008; Clarkson et al. 2005a; 
Erskine et al. 2014) although this is contentious as other studies found no such differences 
between genotypes (Hanson et al. 2010; Norman et al. 2009). While muscle fiber 
composition is not affected by α-actinin-3 deficiency (Norman et al. 2014; Norman et al. 
2009), the cross-sectional area of type II muscle fibers might be larger in RR than in XX 
individuals (Broos et al. 2016). Nonetheless, α-actinin-3 deficiency does not totally preclude 




































































elite power/sprint athletes have reported a normal frequency of XX individuals (Ruiz et al. 
2011; Sessa et al. 2011; Wang et al. 2013; Ruiz et al. 2013).   
It has been proposed that the higher capacity of RR individuals to perform in 
speed/power sports might be also coupled with a better response to strength, and power 
oriented training (Pickering and Kiely 2017).  For example, Delmonico et al. (2007) found 
greater increases in knee extensor peak power after 10 weeks of unilateral strength training 
in RR men and women compared to their XX counterparts.  Norman et al. (2014) reported a 
higher exercise-induced increase in the phosphorylation of the mammalian target of 
rapamycin (mTOR) and p70S6k proteins in R allele carriers compared to the XX allele 
carriers’ in human muscle fibers, suggesting an ameliorated muscle protein synthesis in α-
actinin-3 deficient individuals. The Actn3 KO mouse, firstly generated by MacArthur et al. 
(2007), mimics the α-actinin-3 deficient phenotype in humans. The Actn3 knockout mice 
have identical morphological characteristics to wild type (WT) mice and they compensate 
the lack of α-actinin-3 with α-actinin-2 (Lee et al. 2016).  In this mouse model, it has been 
found there is a higher calcineurin activity in Actn3 KO mice (Seto et al. 2013) that would 
suggest a unfavourable physiological adaptability of α-actinin-3-deficient individuals to 
strength and power training stimuli ((Seto et al. 2013; Garton et al. 2014; Chin et al. 1998); 
Table 2). Indeed, calcineurin is a cytoplasmic calcium-regulated phosphatase implicated in 
fiber type transformations (Dunn et al. 1999), where activation in skeletal muscle selectively 
up-regulates promoters of specific slow-fiber genes (Chin et al. 1998).  In this context, the 
muscle tissue of α-actinin-3-deficient individuals theoretically might be more prone to adapt 
to endurance training stimuli rather than to strength or power oriented programs (Seto et al. 
2013; Garton et al. 2014). 
While these investigations provide mechanistic support for an increased training 
response to strength/power-oriented programs in individuals who are able to express α-




































































A report on the combined association of ACTN3 and angiotensin converting enzyme (ACE) 
insertion (I)/deletion (D) genotypes in older women found that non α-actinin-3 deficient 
genotype (ACTN3 RR) combined with the ACE DD genotype might favour training gains in 
muscle strength, power and functionality (i.e., during the sit-stand test) after a 12-week 
speed/power training protocol (Pereira et al. 2013b; Pereira et al. 2013a). The effectiveness 
of personalized resistance training based on genetics requires further investigation as it has 
only proven effective in one investigation, which included a cumulative genotype score 
based on ACTN3 R77X and 14 other genetic polymorphisms (Jones et al. 2016).  Finally, 
other investigations have not found higher strength gains in RR individuals when compared 
to XX counterparts (Erskine et al. 2014; Clarkson et al. 2005a). Thus, the evidence available 
does not suffice yet to support that RR individuals are more prone to obtain benefits from 
strength or power-based exercise programs than XX individuals. 
 
CONSEQUENCES OF α-ACTININ-3 DEFICIENCY ON ENDURANCE-ORIENTED 
PERFORMANCE 
Recent literature has shown that the absence of α-actinin-3 within the skeletal muscle 
might be advantageous in certain and specific situations, explaining the survival of the 
ACTN3 577X homozygosity through natural selection.  In mouse model studies it has been 
found that there is a shift towards a more efficient aerobic muscle metabolism  coupled with 
an improved recovery from fatigue in Actn3 KO mice vs WT littermates (MacArthur et al. 
2008; MacArthur et al. 2007; Chan et al. 2008).  Actn3 KO mice present with a higher 
activity of key oxidative enzymes, especially in fast muscle fibers, such as NADH-
tetrazolium reductase and succinate dehydrogenase (MacArthur et al. 2007). This indicates 
an enhanced capacity for fat/carbohydrate oxidation during repeated and moderate-intensity 




































































or the XX genotype for endurance sports performance is less clear, with some investigations 
reporting no increased frequency of the XX genotype in endurance athletes (Grealy et al. 
2013; Guilherme et al. 2018; Papadimitriou et al. 2018; Ma et al. 2013; Lucia et al. 2006; 
Saunders et al. 2007; Yang et al. 2007) or even an under-representation of this genotype 
(Ahmetov et al. 2010; Kikuchi et al. 2016; Li et al. 2017) respect to control/untrained 
populations. Thus, it can be assumed that perhaps lack of α-actinin-3 does not offer a major 
advantage for endurance performance, at least in athletic populations (Table 1).  
Regarding training adaptations, XX might be more of a ‘responder’ (i.e., able to 
improve fitness outcomes) to endurance training than those with the RR genotype (Jones et 
al. 2016; Pickering and Kiely 2017).  Actn3 KO mice showed an improved adaptive response 
to 4 weeks of endurance training compared to WT mice (Seto et al. 2013).  Interestingly, the 
muscle of WT mice did not display a shift in fiber type in response to endurance training 
whereas, Actn3 KO mice had a decrease in the cross-sectional area of 2B fibers (which is the 
fastest muscle fiber type in mice) and an increase in 2X fibers, suggesting a "slowing" of the 
metabolic and physiological properties of fast fibers in this α-actinin-3 deficient mice (Seto 
et al. 2013).  Further physiological changes within the muscle fiber produced by the lack of 
α-actinin-3 is higher calcineurin activity, which has been found in both Actn3 KO mice and 
humans with the XX genotype (Seto et al. 2013). In this context, the muscle tissue of α-
actinin-3-deficient individuals theoretically might be more prone to adapt to endurance 
training stimuli rather than to strength or power oriented programs (Seto et al. 2013; Garton 
et al. 2014). Although Silva et al. (2015) found that RR individuals presented a higher 
adaptive response to endurance training than those with the XX genotype (Silva et al. 2015), 
Magi et al. (2016) found no influence of ACTN3 genotype on the peak oxygen consumption 
responses to 5 years of endurance training in young cross-country skiers.  The contradictory 
results might be due, at least partly, to differences between studies in the training protocols 




































































field should be carried out in both detrained and highly endurance trained individuals, with 
proper standardizations in the protocols used for training and controlling for factors that 
could affect trainability, such as the use of concurrent training sessions or of nutritional 
supplements and ergogenic aids.  
 
THE ROLE OF α-ACTININ-3 TO REDUCE EXERCISE-INDUCED MUSCLE 
DAMAGE  
Exercise-induced muscle damage is a physiological process that typically occurs 
after unaccustomed exercise, particularly if the exercise involves a large amount of eccentric 
contractions (Clarkson and Hubal 2002). This phenomenon is associated with muscle 
soreness and is thought to start with mechanical disruption of the affected fibers (e.g., as 
manifested by Z-line streaming), which in turn leads to an inflammatory response. Surrogate 
markers such as increased levels of pro-inflammatory cytokines, and leakage of intra-muscle 
proteins in the blood, such as creatine kinase (CK), are used to assess exercise-induced 
muscle damage (Yamin et al. 2010). The protective role of α-actinin-3 against damage in 
type II muscle fibers has been shown in several research protocols that included acute 
eccentric or concentric muscle actions. Individuals with the XX genotype presented with 
higher serum CK levels and muscle pain values than RR individuals after a protocol of 
eccentric knee extensions (Vincent et al. 2010).  Similarly, XX soccer players showed higher 
serum CK concentrations than their R allele counterparts after a session of plyometric 
exercise (Pimenta et al. 2012). The athletes carrying the X allele presented higher reductions 
in jump height, and higher values of serum CK and self-reported muscle pain than RR 
athletes after a marathon (Del Coso et al. 2017a) or a half-ironman triathlon (Del Coso et al. 
2016). XX individuals also presented with higher serum concentrations of serum myoglobin 




































































role of α-actinin-3 for defending against damaging muscle activities during endurance/ultra-
endurance exercise is somewhat unexpected when considering that slow-twitch fibers are 
preferentially recruited during these exercise tasks (Asp et al. 1999; North 2008). Perhaps, 
α-actinin-3 plays a role during the eccentric phase of endurance exercise activities that 
confers a higher capacity to the muscle, as a whole, to resist muscle damage despite the 
restricted expression of this protein to fast-twitch fibers.   
Other investigations did not find an association between ACTN3 R577X genotypes 
and muscle damage induced by elbow flexion eccentric exercises (Clarkson et al. 2005b).  
Interestingly, the “repeated-bout effect”, that is, performing one bout of eccentric exercise 
to induce an adaptation such that the muscle is less vulnerable to muscle damage in a 
subsequent bout of the same type of exercise (Starbuck and Eston 2012) might be more 
marked in XX than in RR individuals suggesting that XX might be able to undertake more 
frequent training sessions (Venckunas et al. 2012). This finding was reported using drop 
jumps as the only exercise model to induce muscle damage and therefore requires further 
corroboration with other forms of exercise. A recent study found that, rather than the ACTN3 
R577X variant only, it was the cumulative influence of several genetic polymorphisms 
(including ACTN3 R577X) that was associated with the magnitude of muscle damage after 
a marathon (Del Coso et al. 2017b). This latter investigation agrees with a previous analysis 
in which the ACTN3 R577X genotype, in combination with other genes, was related to an 
increased likelihood of suffering a clinical case of exertional rhabdomyolysis (Deuster et al. 
2013).  Thus, the presence of α-actinin-3 could offer a structural benefit within the skeletal 
muscle fiber that might reduce the damage produced in the sarcomere during exercise but 
with other hereditable factors involved in the phenotype of resistance against muscle fiber 
damage. In this regard, the upregulated production of α-actinin-2 in muscle fibers found in 
XX individuals (Seto et al. 2011) does not suffice to prevent a higher likelihood of muscle 





































































α-ACTININ-3 DEFICIENCY AND MUSCLE INJURY  
The influence of the ACTN3 R577X genotype on the levels of exercise-induced 
muscle damage, with the latter being a physiological phenomenon, might also suggest that 
α-actinin-3 deficiency can be associated with a higher incidence or severity of exercise-
related muscle injuries (i.e., a pathological phenomenon that might sometimes be linked to 
initial muscle damage, muscle contractures and strains, etc). It has been reported that XX 
soccer players (first league division, Italy) had almost a three- and two-fold higher 
probability of suffering muscle injuries in general and severe muscle injuries, respectively, 
than their RR counterparts (Massidda et al. 2017). Yet, another study found that R allele 
carriers had an increased likelihood of suffering non-contact muscle injury during different 
sports-activities when compared to X allele carriers (Iwao-Koizumi et al. 2015). 
Interestingly, the authors hypothesised that the presence of α-actinin-3 would be associated 
with a higher magnitude of muscle strength in R allele carriers that would have produced a 
higher muscle strain during exercise, thereby explaining their results. In this regard, R allele 
carriers had increased passive hamstring stiffness compared to non-carriers, although this 
mechanical property did not increase the risk of strain injury (Miyamoto et al. 2018). In 
athletes of combat sports (judo, taekwondo, boxing), subjects with the XX genotype had a 
similar kinematic efficacy in the lower limbs than R allele carriers, as assessed with knee, 
angle and pelvis moments during a sprint with a change of direction and a vertical jump 
(Jung et al. 2016).  Thus, the evidences that relate deficiency of α-actinin-3 with a higher 





































































α-ACTININ-3 DEFICIENCY AND OTHER TYPES OF INJURIES  
Although the absence of α-actinin-3 in skeletal muscle fibers has not been linked with 
significant changes in connective or ligament tissues, dancers with the XX genotype show a 
higher incidence of ankle injuries than R allele carriers (Kim et al. 2014b). The XX genotype 
has also been associated with a higher incidence of non-contact acute ankle sprains (Qi et al. 
2016; Shang et al. 2015), although this association has not been replicated by others (Kim et 
al. 2017a). If accurate, the higher likelihood of injury in α-actinin-3 deficient individuals 
might be related to a dysfunction in the capacity of the muscle to hold the joint during the 
action, rather than to a dysfunction of the ligament tissue (Pickering and Kiely 2017). 
Another factor that is intrinsically related to the risk of joint injuries during exercise is the 
range of motion in active joints and muscle flexibility. In this context, Zempo et al. (2016) 
found that RR individuals had lower trunk flexibility than X allele carriers, as measured by 
the sit-and-reach test. This was replicated by Kikuchi et al. (2017) in a similar investigation 
with untrained individuals. However, a lower trunk flexibility has been found in XX 
ballerinas when compared to R allele carriers (Kim et al. 2014b). In regards to other joints, 
a reduced range of motion in the elbow has been found in RR homozygotes (Kikuchi et al. 
2018). The discrepancies in the outcomes of these investigations indicates that a clear effect 
of the ACTN3 R577X genotype on muscle flexibility and range of motion is yet to be 
elucidated.   
In addition to its presence in fast glycolytic skeletal muscle fibers, α-actinin-3 is 
expressed in osteoblasts. Actn3 KO mice presented lower bone mineral density and bone 
formation rates per unit of bone surface when compared to WT littermates, suggesting that 
the lack of α-actinin-3 is associated with disruptions in mineralisation and resorption (Yang 
et al. 2011) . α-actinin-3 deficient humans also presented with lower levels of bone mineral 
density (Yang et al. 2011; Min et al. 2016), as well as higher values of serum bone 




































































suggests that XX genotype may contribute to a higher likelihood of bone injury during 
exercise but to the date, there is no evidence for an effect of the ACTN3 genotype on the risk 
or severity of bone injuries during exercise activities.  
There is need for more research to clearly associate α-actinin-3 deficiency with injury 
risk in athletic and non-athletic populations.  The use of genome-wide association studies 
might be effective in helping to fill the gaps of why some individuals are more susceptible 
to injury than others. This has already been found useful to explain higher risk of rotator cuff 
injury (Roos et al. 2017), Achilles tendinopathy and anterior cruciate ligament rupture (Kim 
et al. 2017b) and ankle injuries (Kim et al. 2017a).   
 
SUMMARY AND CONCLUSIONS 
ACTN3 R577X genotype influences human performance in several manners related 
to the structural, metabolic and signalling effects by the absence or presence of α-actinin-3 
within the skeletal muscle. Table 3 includes an evidence-based analysis of the association 
between ACTN3 genotype and different muscle phenotypes in human and animal 
experiments. The RR genotype, which results in the full expression α-actinin-3 in fast-twitch 
fibers, favours the ability to generate powerful and forceful muscle contractions, leading to 
an overall advantage of this genotype for performance in some speed and power sports. 
Although more research is needed, this genotype might also favour the ability to withstand 
exercise-induced muscle damage. On the other hand, theoretically a beneficial influence of 
the XX genotype on aerobic exercise performance remains to be corroborated in human 
studies.  More information is required to unveil the association of ACTN3 genotype with 
injury risk during acute or chronic exercise.   
Most of the information included in this review refers to research on ACTN3 




































































Hence, it is still too early to determine whether the information that is currently available on 
the ACTN3 genotype-phenotype associations can be directly used for genetic testing in the 
general/amateur population. Studies on the impact of α-actinin-3 deficiency in amateur 
athlete populations with more ecological research protocols should be the focus of future 
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Figure 1.  Localisation of α-actinin in skeletal muscle.  
The sarcomeric α-actinins are essential for the contractile apparatus at the Z-line because 
they bind and cross-link the ends of F-actin filaments from adjacent sarcomeres. While the 
expression of α- actinin-2 is ubiquitous in all types of muscle fibers, α-actinin-3 is restricted 
to fast type II fibres, suggesting a different physiological role of each isoform for muscle 
contraction. α-actinins are antiparallel homodimers of more than 200 kDa, comprising an 
actin-binding domain (ABD), a central domain of four spectrin-like repeats (SR1-4), and a 
C-terminal calmodulin-like domain with two pairs of EF hand motifs (EF).  Adapted from 






































































Figure 2.  Most common phenotypes related to α-actinin-3 deficiency due to 
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Table 1.  Summary of the physiological/performance consequences of α-actinin-3 deficiency in humans. 
 Sprint/power Endurance Muscle damage Trainability Risk of injury 
 
Overview ↓ sprint/power performance 
↓ muscle strength 
Mixed results for 
endurance performance 
and fatigue resistance 









↑ risk of ligament 
injury and mixed 
results for risk of 





↓ capacity to generate 
muscle force and power 
specially in muscle 
contractions that requires the 
recruitment of type 2 muscle 
fibers 
↑ metabolic efficiency  
↑ aerobic metabolism 
↓ capacity to resist 
muscle strain during 








↓ capacity to resist 
muscle strain that 
could lead to reduced 
joint stability 
↑ ligament tension 
 
Consequence 
for exercise and 
sport 
↓ frequency of XX 
individuals although this 
effect is minor in strength-
based disciplines 
↑ frequency of XX 
individuals initially 
found but this has been 
disputed in more recent 
investigations.  
↑ levels of serum 
markers of muscle 
damage 




been identified in 
sport 
↑ frequency of XX 
individuals among 
patients with ankle 
joint injuries 




Abbreviation: mTOR, mammalian target of rapamycin 
 
Table 1
Table 2.  Summary of the physiological consequences of α-actinin-3 deficiency identified with the knock-out mouse model for the α-actinin-3 
gene (Actn3). 
 Metabolic Signalling Structural Calcium-handling 
 
Overview Shift towards more 
aerobic metabolism 
↑ adaptive response to endurance 
stimuli 
Altered contractile properties Altered calcium kinetics  
      
Mechanism ↑ oxidative enzymes and 
↓ glycolytic enzymes  
↑ calcineurin activity ↑ expression of Z-line proteins ↑ calcium release and 
absorption 
 
      
Physiological 
impact 
↑endurance capacity and 
resistance to fatigue 
↑ endurance trainability ↓ production of force ↑ production of metabolic heat  
      
Further 
considerations 
It is the result of changes 
in various enzymes 
It is the result of the preferential 
binding of calsarcin 2 to α-
actinin-2 
It is the result of the preferential 
binding of Z-line proteins to α-
actinin-2 




Abbreviations: SERCA1, Sarcoplasmic/endoplasmic reticulum calcium ATPase 1. 
Table 2
Table 3.  Level of evidence from human and mouse model research for the effects of the α-actinin-3 deficiency on different muscle phenotype 
traits. 
Muscle trait Human Mouse Applications for exercise References for human studies 





Genotyping can be used to 
determine the likelihood of 
success in a sprint/power-based 
sport 
(Alfred et al. 2011; Yang et al. 
2003; Weyerstrass et al. 2018; Ma 
et al. 2013; Eynon et al. 2013; 
Kikuchi et al. 2014) 
(MacArthur et al. 2008; 
Quinlan et al. 2010; Lee et al. 
2016; North 2008) 




Too early to use personalise 
endurance training based on 
ACTN3 genotyping  
(Silva et al. 2015; Magi et al. 2016) 





Genotyping does not seem 
useful for detection of 
endurance talents 
(Yang et al. 2003; Silva et al. 2015; 
Pasqua et al. 2016; Eynon et al. 
2012) 
(MacArthur et al. 2007; Chan 
et al. 2008; Seto et al. 2013; 
North 2008) 
↓ training response 
to strength training 
IV II 
Too early to personalise 
strength training based on 
ACTN3 genotyping  
(Norman et al. 2014; Delmonico et 
al. 2007) 
(Garton et al. 2014; Seto et al. 
2013; Lee et al. 2016) 
↑ risk of muscle 
damage 
II IV 
Specific training might be used 
to ameliorate muscle damage in 
XX individuals 
(Vincent et al. 2010; Del Coso et al. 
2017a; Del Coso et al. 2016) 
(Seto et al. 2011) 




Prevention plans to reduce 
ligament injuries in XX 
individuals 
(Massidda et al. 2017; Kim et al. 
2014b; Qi et al. 2016; Shang et al. 
2015) 
- 
↑ risk of bone injury IV IV 
Too early to develop prevention 
plants to avoid bone injuries in 
XX individuals 
(Yang et al. 2011; Min et al. 2016; 
Levinger et al. 2017) 
(Yang et al. 2011) 
 
Table 3
Level I:  Systematic and narrative reviews, meta-analyses and high-quality prospective cohort studies with adequate power and with consistent 
results regarding the association of ACTN3 genotype and the specific muscle trait.  Level II:  Lesser high-quality prospective cohort studies, 
retrospective/comparative studies or systematic reviews and meta-analysis with inconsistent results regarding the ACTN3 genotype and the specific 
muscle trait. Level III:  Case-control and retrospective studies with inconsistent results regarding the association of ACTN3 genotype and the 
specific muscle trait.  Level IV:  Absence of association between the ACTN3 genotype and the specific muscle trait or inconsistent results derived 
from cases series or poorly referenced investigations with no sensitivity analyses of phenotypes. Level V:  Expert opinion. Adapted from (Burns 
et al. 2011).  Abbreviation: ACTN3, α-actinin-3 gene. 
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